Recent Articles

September 19, 2016 4:10 pm
Ryan Bushey
The Swiss drug maker could have a strong contender to treating a rare form of multiple sclerosis.
September 16, 2016 12:04 pm
Ryan Bushey
The Danish drug maker's once-weekly injectable therapy hit an important milestone in a recent study.
September 16, 2016 10:00 am
Dominic Trewartha, Managing Analyst, GBI Research
Current first-in-class approaches to treatment have being gaining significant traction in preclinical and clinical trials.
September 16, 2016 8:26 am
Valerie Malyvanh Jansen and Ingrid Mayer, Vanderbilt University, The Conversation
There has been substantial publicity about the MINDACT trial, which could lead to changes in breast cancer treatment.
September 15, 2016 1:00 pm
GlobalData
An increase in health expenditure reflects the government’s interest in supporting the growth of the healthcare sector.
September 15, 2016 8:55 am
Mark Fischer-Colbrie, CEO, Labcyte
The concept of individualized system medicine could dramatically improve outcomes for patients and reduce health care costs by eliminating rounds of expensive and potentially toxic therapy that have little effect on cancer but can severely diminish quality of life.
September 14, 2016 9:24 am
Ryan Bushey
The company will present more detailed data this week at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis in London, England.
September 13, 2016 3:23 pm
Ryan Bushey
Celgene’s announcement regarding its promising oral candidate to treat Crohn’s disease was difficult to interpret for some financial analysts.
September 12, 2016 3:16 pm
Ryan Bushey
Each company is investing up to $248 million each for this startup.
September 9, 2016 3:15 pm
Ryan Bushey
The issue of high drug prices has raised a number of concerns with insurers and employers searching for strategies to provide patients with the most cost-effective payment plans.
Subscribe to Drug Discovery & Development